To examine whether the combined treatment of MGF and T0 exerts hypolipidemic effects in atherosclerotic plaque formation without fatty liver and hyperglyceridemia, Apoe−/− mice fed with HFD were administrated with T0, MGF or both T0 and MGF by gavage for 16 weeks. This evidence concerns the gene APOE and fatty liver disease.